101 |
|
Explaining hump-shaped inflation responses to monetary policy shocks
|
Yetman, J.
|
John Wiley & Sons, Ltd
|
2007
|
|
|
102 |
|
Price rigidities, inventories, and growth fluctuations
|
Tsoukis, C.; Naqvi, N.
|
John Wiley & Sons, Ltd
|
2007
|
|
|
103 |
|
Costly price adjustment and the optimal rate of inflation
|
Konieczny, J. D.
|
John Wiley & Sons, Ltd
|
2007
|
|
|
104 |
|
Contests with investment
|
Munster, J.
|
John Wiley & Sons, Ltd
|
2007
|
|
|
105 |
|
Why do firms both make and buy? An investigation of concurrent sourcing
|
Parmigiani, A.
|
John Wiley & Sons, Ltd
|
2007
|
|
|
106 |
|
Strategic schemas, strategic flexibility, and firm performance: the moderating role of industry clockspeed
|
Nadkarni, S.; Narayanan, V. K.
|
John Wiley & Sons, Ltd
|
2007
|
|
|
107 |
|
The cost of US pharmaceutical price regulation: a financial simulation model of R&D decisions
|
Abbott, T. A.; Vernon, J. A.
|
John Wiley & Sons, Ltd
|
2007
|
|
|
108 |
|
Uncertainty and choice: the challenges of pharmaceutical efficacy, safety, and cost
|
Scherer, F. M.
|
John Wiley & Sons, Ltd
|
2007
|
|
|
109 |
|
`Branded Generics' as a strategy to limit cannibalization of pharmaceutical markets
|
Reiffen, D.; Ward, M. R.
|
John Wiley & Sons, Ltd
|
2007
|
|
|
110 |
|
Why do prices rise faster than they fall? With an application to mortgage rates
|
Toolsema, L. A.; Jacobs, J. P.
|
John Wiley & Sons, Ltd
|
2007
|
|
|